Radiofrequency ablation in metastatic disease.
The liver is the most common site of metastas from colorectal cancer. Hepatic metastases are the major cause of morbidity and mortality in those patients. Surgical resection provides the greatest potential for cure in patients with secondary liver tumors but can be offered to only a small number of patients (5%-20%). In selected patients image-guided radiofrequency ablation (RFA) takes over the role as curative treatment option, especially in patients who are technically not eligible for surgery. Technical aspects, criteria for patient selection, aspects concerning follow-up imaging and results of percutaneous radiofrequency ablation in liver metastases from colorectal cancer are discussed.
Lubienski
Andreas
A
Department of Diagnostic Radiology, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany. lubienski@med.uni-heidelberg.de
D017115:Catheter Ablation; D015179:Colorectal Neoplasms / Q000473:pathology*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary*; D009362:Neoplasm Metastasis / Q000628:therapy*; D011878:Radiotherapy / Q000379:methods; D014057:Tomography, X-Ray Computed